5paisa capital has scheduled a board meeting for March 11, 2026, to finalize the terms of its rights issue, following the initial approval granted by the board on February 24, 2026. The meeting will address various critical aspects of the capital raising exercise that could raise up to ₹ 4,750.00 million for the company.

Rights Issue Details and Board Approval

The company's board had previously approved the raising of funds through the issuance of fully paid-up equity shares with a face value of ₹ 10 each by way of a rights issue. The issue is targeted at eligible shareholders as on the record date, which is yet to be determined and will be notified subsequently.

Upcoming Board Meeting Agenda

The March 11, 2026 board meeting will focus on determining the specific terms of the rights issue. Key matters to be discussed and decided include:

• Determination of the issue price
• Rights entitlement ratio for existing shareholders
• Setting the record date for eligibility
• Timing and schedule of the issue
• Other incidental matters related to the issue

Regulatory Compliance Framework

The rights issue will be conducted in accordance with multiple regulatory frameworks and statutory requirements. The company has ensured compliance with the Companies Act, 2013, along with its amendments and associated rules. Additionally, the issue will follow the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable laws.

Communication and Transparency

The company has fulfilled its disclosure obligations under Regulation 29 of the SEBI Listing Regulations by informing both BSE Limited and The National Stock Exchange of India Limited about the scheduled board meeting. The intimation has also been uploaded to the company's official website at www.5paisa.com , ensuring transparent communication with all stakeholders.

The notification was signed by Charvi Panchmatia, Company Secretary & Compliance Officer, on March 06, 2026, demonstrating the company's commitment to timely regulatory compliance and stakeholder communication.

5paisa capital Limited has announced that it has received a Certificate of Registration as a Research Analyst from the Securities and Exchange Board of India (SEBI). The approval was communicated through SEBI's email dated February 26, 2026, with the company making the disclosure on February 27, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Registration Details

The registration certificate has been granted under the SEBI (Research Analysts) Regulations, 2014, which will enable the company to undertake and carry on activities as a Research Analyst in accordance with applicable regulations.

Business Impact

According to the company's disclosure, this registration is expected to support 5paisa Capital's business activities by allowing it to conduct research analyst operations. The certificate enables the company to expand its service offerings within the regulatory framework established by SEBI for research analysts.

Regulatory Compliance

The certificate is valid for a period of five years from the date of grant of registration, subject to payment of applicable renewal fees as prescribed under the SEBI (Research Analysts) Regulations, 2014. The company has made this disclosure in compliance with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Key Features

• Registration allows research analyst activities under SEBI regulations
• Five-year validity period with renewal option
• Expected to enhance the company's business capabilities
• Full compliance with SEBI disclosure requirements

The disclosure was signed by Charvi Panchmatia, Company Secretary & Compliance Officer, and submitted to both BSE Limited and the National Stock Exchange of India Limited as required under the listing regulations.